Guided Therapeutics Inc. (OTCMKTS:GTHP) Short Interest Update

Guided Therapeutics Inc. (OTCMKTS:GTHP) was the recipient of a significant drop in short interest during the month of July. As of July 15th, there was short interest totaling 1,437 shares, a drop of 92.7% from the June 30th total of 19,653 shares. Based on an average daily trading volume, of 29,293 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company’s shares are sold short.

Guided Therapeutics Stock Performance

Shares of GTHP remained flat at $0.26 during trading hours on Friday. The stock had a trading volume of 13 shares, compared to its average volume of 8,281. Guided Therapeutics has a 1 year low of $0.12 and a 1 year high of $0.54. The company’s 50-day moving average is $0.24 and its 200 day moving average is $0.28. The firm has a market cap of $25.10 million, a price-to-earnings ratio of -6.50 and a beta of 0.72.

Guided Therapeutics (OTCMKTS:GTHP) last issued its earnings results on Friday, May 15th. The company reported ($0.01) earnings per share for the quarter.

About Guided Therapeutics

Guided Therapeutics, Inc is a medical device company focused on the development and commercialization of non‐invasive optical diagnostic platforms for women’s health. Its flagship product, the LuViva® Advanced Cervical Scan, combines hyperspectral and reflectance imaging to support the early detection of cervical epithelial abnormalities. By capturing tissue fluorescence and reflectance signatures in real time, LuViva is designed to augment traditional visual inspection methods and assist clinicians during colposcopic evaluations.

The company secured 510(k) clearance from the U.S.